Searched for
TARO
Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- Arunachal Pradesh CM Khandu seeks Centre's sustained support to strengthen strategic border infraArunachal Pradesh Chief Minister Pema Khandu met Defence Minister Rajnath Singh. He requested continued central support for strategic infra...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Arunachal CM Pema Khandu meets with Rajnath Singh, seeks support for critical infraArunachal Pradesh Chief Minister Pema Khandu met Defence Minister Rajnath Singh in New Delhi. He requested ongoing assistance for crucial i...
- Sun Pharma completes merger of TaroAs part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its...
- Taro shareholders approve merger with Sun PharmaThe combined entity will enable the company to better serve the needs of patients, healthcare professionals and customers around the world,...
- Sun Pharma to buy remaining 21.5% in Taro for Rs 2,892 crSun Pharma, India's largest drugmaker, is set to acquire the remaining 21.52% stake in Israel-based Taro Pharmaceutical Industries for ₹2,8...
- Taro stake buyout to help operate its dermatology biz profitably amid enhanced competition: Sun PharmaThe company has issued a letter to the Taro board with a proposal containing a non-binding indication of interest to acquire all of the out...
- Taro stake buyout to help operate its dermatology biz profitably amid enhanced competition: Sun PharmaSun Pharma is looking to fully acquire its Israel-based unit Taro Pharmaceutical Industries in order to integrate the dermatology business ...
- Taro appoints Sun Pharma CFO Uday Baldota its CEOBaldota, who has also been nominated to Taro's board of directors, is expected to begin his role as CEO on or about April 1, 2017, and will...
- Taro appoints Mariano Balaguer its new CFOTaro said Balaguer comes with 20 years of experience in finance with global companies such a Novartis Consumer Health, Nestle and Henry Sch...
- Sun Pharma under scanner for under-reporting Taro's Q3 resultsA minority shareholder of Taro Pharma has alleged that the company's financial results have been under-reported by its Indian promoter, Sun...
- Taro Pharma panel turns down Sun Pharma's open offer priceSun Pharma, which holds about 67% stake in Taro, had made an open offer of $24.50 a share last year for the remaining stake.
- Guardian Point asks Sun Pharma to up Taro Pharma offerGuardian Point Capital, one of the minority shareholders of Israeli firm Taro Pharma, has asked Sun Pharma to revise $24.50 share price off...
- Sun Pharma says won't revise taro offer priceMumbai-based Sun Pharma will not revise its offer price to minority shareholders of Isreali drug maker Taro pharma, a company official said.
- Taro integration worries weigh on Sun Pharma investorsThe latest verdict of the Israeli Supreme Court will enable Sun Pharma to increase its stake in Taro to around 53 per cent.
- 'We hope to get control of Taro'Sun Pharmaceutical chairman & managing director, Dilip Shanghvi told that Taro acquisition still seems attractive three years later.
- Sun rejects Guggenheim’s $215 mn offer for Taro stakeGuggenheim Partners offered to buy Sun Pharmaceutical Industries’ stake in Taro Pharmaceuticals Industries on behalf of clients for about $...
Load More
